PATENT CLAIM ANALYSIS

Application Number: 15886057
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "210180"]

Abstract:
This invention relates to compounds that are agonists of the muscarinic M 1  receptor and/or M 4  receptor and which are useful in the treatment of muscarinic M 1 /M 4  receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula (1a) or a salt thereof, wherein p, q, r, s, Q, R 3  and R 4  are as defined herein.

Claim (Index 39):
The compound according to  claim 26  which is ethyl 2-{4-[ethyl(methoxy)amino]piperidin-1-yl}-6-azaspiro[3.4]octane-6-carboxylate or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 88.0
- Lexical Diversity: 1.53571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15699674', '15749743', '15227325', '15559375', '15117018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8178885761939991
- 35 USC 102 Novelty (BERT): 0.5792735885731333
- Combined Prediction Score: 0.7940270774319126
- Mean Citation Score: 368.160338
- Max Citation Score: 470.58286
- Similarity Product: 437.9367171146728

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test